NTHRYS › PhD Assistance › Ai Bispecific Antibodies

Ai Bispecific Antibodies

Field

▾

Ai Bispecific Antibodies

Select a category to explore research frontiers

Loading categories...

Research Frontiers in Dose Optimisation In Clinical Development

Doctoral study addresses identification of doses balancing efficacy and tolerability. Maximum tolerated dose approaches suit these molecules particularly poorly.

All AI Bispecific Antibodies PhD categories